Jamal Rana MD FACC/LinkedIn
Nov 11, 2025, 23:38
The Wall Street Journal Features Major AHA Trials on Cholesterol Breakthroughs
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, posted on LinkedIn:
”Many reached out requesting access to read the full article. The story made it to the print version, given this was The Wall Street Journal’s main coverage of the biggest trials presented at AHA Scientific Sessions 2025. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high-risk patients to prevent heart disease.
Link here.”
Stay updated with Hemostasis Today.
AHA
American College of Cardiology
American Heart Association
Atherosclerosis
Betsy McKay
Cardiology
Cholesterol
European Atherosclerosis Society
Health
Heart Disease
Heart Health
Hematology
Hemostasis
Hemostasis Today
Jamal Rana
Kaiser Permanente Bernard J. Tyson School of Medicine
Medicine
The Wall Street Journal
thrombosis
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera